Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000903-10Phase 4Completed
Phase 4, open-label, single-arm trial of hydromorphone, sponsored by Oulu University Hospital. Primary endpoints: Maternal hydromorphone blood concentration during labour, Neonatal hydromorphone concentration in umbilical vein and 1 more. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000903-10.